The agency approved a monthly dosing option for select patients acorss all approved indications, including wAMD, DME, DR, and RVO. FDA approved aflibercept (Eylea HD) 8 mg for macular edema following ...

National CPS data from 2012-2023 show declines in confirmed child maltreatment, but disparities remained, particularly among Black and female children. Confirmed child maltreatment declined, but ...

Can you diagnose this patient? Take our poll and find out! Then check back for the full case, differential diagnosis, and correct diagnosis. His vital signs in clinic were within normal limits, and ...

Joshua Fitch is the senior editor for Contemporary Pediatrics. He joined the brand in March of 2023 as an editor before being promoted to senior editor in January 2024. Fitch graduated from Youngstown ...

Dr. Carroll is a clinical assistant professor, Tulane University School of Medicine, and section head of Pediatric Hospital Medicine, Ochsner Health System, New Orleans, Louisiana.

Despite the growing involvement of fathers in their children’s lives, there persists a lack of focus on fathers in pediatric care. Updated guidelines can help pediatricians to better engage fathers in ...

Finding an acceptable alternative to breast milk has proved to be a complicated quest that continues today. Finding an acceptable alternative to breast milk has proved to be a complicated quest that ...

Pediatricians need to recognize symptoms of perinatal depression in new mothers, provide basic counseling and treatment, and refer for appropriate services when needed. Postpartum depression occurs in ...

GLP-1 receptor agonists, used to treat diabetes, are now also being used for obesity in children and adolescents. Pediatric obesity affects more than 14 million children, which is equivalent to 1 in 5 ...

The latest update to the HEEADSSS psychosocial interview for adolescents includes new questions on electronic media use in addition to its time-tested strategies for identifying the critical stressors ...

Pediatric healthcare providers are on the front lines to provide early identification and treatment of plagiocephaly/brachycephaly and torticollis for those infants ...

Specifically, the ACIP voted 5-2 to recommend clesrovimab (Enflonsia; Merck), which was approved by the FDA on June 9, 2025, for infants aged 8 months and younger who are not protected by a maternal ...